Journal of the American Academy of Dermatology
Volume 62, Issue 5 , Pages 874-879 , May 2010

Erythema multiforme during anti–tumor necrosis factor treatment for plaque psoriasis

  • Jennifer Ahdout, BS
    • ,
  • Jennifer C. Haley, MD
    • ,
  • Melvin W. Chiu, MD

      Affiliations

    • Corresponding Author InformationReprint requests: Melvin W. Chiu, MD, Division of Dermatology, Department of Medicine, David Geffen School of Medicine at UCLA, 52-121 Center for the Health Sciences, 10833 Le Conte Ave, Los Angeles, CA 90095.

References 

  1. Tzu J, Kerdel F. From conventional to cutting edge: the new era of biologics in treatment of psoriasis. Dermatol Ther. 2008;21:131–141
  2. van de Kerkhof PC. Consistent control of psoriasis by continuous long-term therapy: the promise of biological treatments. J Eur Acad Dermatol Venereol. 2006;20:639–650
  3. Tracey D, Klareskog L, Sasso EH, Salfeld JG, Tak PP. Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther. 2008;117:244–279
  4. Chang J, Girgis L. Clinical use of anti-TNF-alpha biologic agents—a guide for GPs. Aust Fam Physician. 2007;36:1035–1038
  5. FDA Drug Safety Newsletter. U.S. Food and Drug Administration Web site. Available at: http://www.fda.gov/cder/dsn/2008_winter/toc.htm. Accessed January 10, 2009.
  6. Kain T, MacGregor D, Buchanan RR, de Jager JP, Schachna L. Erythema multiforme with tumor necrosis factor inhibitors: a class effect?. Ann Rheum Dis. 2002;61:850–851
  7. Soliotis F, Glover M, Jawad AS. Severe skin reaction after leflunomide and etanercept in a patient with rheumatoid arthritis. Ann Rheum Dis. 2008;67:899–900
  8. Vergara G, Silvestre JF, Betlloch I, Vela P, Albares MP, Pascual JC. Cutaneous drug eruption to infliximab: report of 4 cases with an interface dermatitis pattern. Arch Dermatol. 2002;138:1258–1259
  9. Huff JC, Weston WL. Isomorphic phenomenon in erythema multiforme. Clin Exp Dermatol. 1983;8:409–413
  10. Habif TP. Erythema multiforme. In:  Habif TP editors. Clinical dermatology. Edinburgh (UK): Mosby; 2004;p. 627–628
  11. Villiger R, von Vigier RO, Ramelli GP, Hassink RI, Bianchetti MG. Precipitants in 42 cases of erythema multiforme. Eur J Pediatr. 1999;158:929–932
  12. Kokuba H, Aurelian L, Burnett J. Herpes simplex virus associated erythema multiforme (HAEM) is mechanistically distinct from drug-induced erythema multiforme: interferon-γ is expressed in HAEM lesions and tumor necrosis factor-α in drug induced erythema multiforme lesions. J Invest Dermatol. 1999;113:808–815
  13. Aurelian L, Kokuba H, Burnett JW. Understanding the pathogenesis of HSV-associated erythema multiforme. Dermatology. 1998;19:219–222
  14. Burnett JW, Laing JM, Aurelian L. Acute skin eruptions that are positive for herpes simplex virus DNA polymerase in patients with stem cell transplantation: a new manifestation within the erythema multiforme reactive dermatoses. Arch Dermatol. 2008;144:902–907
  15. Humira (adalimumab) [package insert]. U.S. Food and Drug Administration Web site. Available at: http://www.fda.gov/cder/foi/label/2002/adalabb123102LB.htm. Accessed January 10, 2009.
  16. Enbrel (etanercept) [package insert]. U.S. Food and Drug Administration Website. Available at: http://www.fda.gov/cder/foi/label/2008/103795s5359lbl.pdf. Accessed January 10, 2009.
  17. Domm S, Cinati J, Mrowietz U. The impact of treatment with tumour necrosis factor-alpha antagonists on the course of chronic viral infections: a review of the literature. Br J Dermatol. 2008;159:1217–1228
  18. Justice EA, Khan SY, Logan S, Jobanputra P. Disseminated cutaneous Herpes Simplex Virus-1 in a woman with rheumatoid arthritis receiving Infliximab: a case report. J Med Case Reports. 2008;2:282
  19. Ng PP, Sun YJ, Tan HH, Tan SH. Detection of herpes simplex virus genomic DNA in various subsets of erythema multiforme by polymerase chain reaction. Dermatology. 2003;207:349–353
  20. Bourrain JL, Woodward C, Dumas V, Caperan D, Beani JC, Amblard P. Natural rubber latex contact dermatitis with features of erythema multiforme. Contact Dermatitis. 1996;35:55–56
  21. Bara C, Milpied B, Geraut C, Stalder JF. Erythema multiforme with occupational rubber contact sensitivity. Contact Dermatitis. 2003;49:269–270
  22. Lu CY, Sun CC. Localized erythema-multiforme-like contact dermatitis from rubber gloves. Contact Dermatitis. 2001;45:311–312
  23. Tatfall F, Schofield J, Leigh I. A double-blind, placebo-controlled trial of continuous acyclovir therapy in recurrent erythema multiforme. Br J Dermatol. 1995;132:267–270

 Funding sources: None.

 Disclosure: Dr Chiu has been a paid consultant for Abbott, Amgen, Connetics, Galderma, and Warner-Chilcott; he has also been an investigator for Amgen. Ms Ahdout and Dr Haley have no relevant conflicts of interest.

PII: S0190-9622(09)00542-8

doi: 10.1016/j.jaad.2009.04.048

Journal of the American Academy of Dermatology
Volume 62, Issue 5 , Pages 874-879 , May 2010

Article Tools

* Image Usage & Resolution